Outstanding Recoveries
- Home
- Outstanding Recoveries
Verdicts & Settlements
Since Milberg’s founding in 1965, the firm has recovered more than $50 billion for our clients while prompting meaningful changes in corporate governance.
Filter By
Select Practice Area
-
See More$68.5 Million Settlement – Parris, et al. v. Meta Platforms
Parris, et al., v. Meta Platforms, Inc., Case No.2023LA000672 (18th Cir. DuPage Cty., Ill.)Milberg served as Lead Counsel in this privacy class action under the Illinois Biometric Information Privacy Act. Milberg obtained a settlement of $68.5 million in 2023. -
See More$178.6 Million Settlement – AK Steel ERISA Class Action
Merkner et al. v. AK Steel Corp., No. 09-423 (S.D. Ohio)Milberg attorneys were part of a team that won a $178.6 million class action settlement for a class of retired workers of the AK Steel Butler Works Plant. Retirees claimed that AK Steel negotiated to reduce their medical benefits without their consent, in violation of the Employee Retirement Income Security Act (ERISA). -
See More$110 Million Settlement – CVS Corp. Securities Litigation
In re CVS Corp. Securities Litigation, No. 01-11464 (D. Mass.)Milberg served as Co-Lead Counsel in this securities class action alleging that defendants issued false and misleading statements, which artificially inflated the price of CVS stock. In 2005, the court approved a $110 million settlement. -
See More$138 Million Settlement – Biovail Corp. Securities Litigation
In re Biovail Corp. Securities Litigation, No. 03-8917 (S.D.N.Y.)Milberg, representing Local 282 Welfare Trust Fund and serving as Co-Lead Counsel, litigated this securities action alleging that defendants made misleading statements concerning Biovail’s financial results and its drug, Cardizem LA. Following substantial discovery, including depositions across the U.S. and Canada, Milberg obtained a $138 million settlement for the class, and Biovail agreed to institute significant corporate governance changes. -
See MoreTrump Hotels Shareholder Derivative Litigation
In re Trump Hotels Shareholder Derivative Litigation, No. 96-7820 (S.D.N.Y.)The plaintiff shareholders asserted various derivative claims on behalf of the company against certain Trump entities and senior Trump executives in connection with the sale of a casino to a company in which the plaintiffs owned stock. Milberg negotiated a settlement requiring the company to increase the number of directors and the review of certain future transactions by a special committee.
